AP
EW icon

AHL Partners’s Edwards Lifesciences EW Stock Holding History

AHL Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$7.34M Buy
195,285
+50,232
+35% +$1.84M 0.11% 335
2017
Q3 		$5.29M Sell
145,053
-18,834
-11% -$718K 0.09% 384
2017
Q2 		$6.46M Buy
163,887
+16,176
+11% +$590K 0.14% 249
2017
Q1 		$4.63M Buy
147,711
+137,169
+1,301% +$4.29M 0.1% 365
2016
Q4 		$329K Sell
10,542
-22,911
-68% -$742K 0.01% 947
2016
Q3 		$1.34M Sell
33,453
-38,613
-54% -$1.45M 0.05% 508
2016
Q2 		$2.4M Buy
72,066
+49,899
+225% +$1.71M 0.13% 209
2016
Q1 		$652K Sell
22,167
-13,125
-37% -$362K 0.04% 503
2015
Q4 		$929K Buy
35,292
+25,236
+251% +$655K 0.07% 369
2015
Q3 		$238K Sell
10,056
-359,694
-97% -$8.68M 0.04% 627
2015
Q2 		$8.78M Buy
369,750
+62,598
+20% +$1.41M 0.35% 27
2015
Q1 		$7.29M Buy
307,152
+55,266
+22% +$1.24M 0.29% 38
2014
Q4 		$5.35M Sell
251,886
-72,588
-22% -$1.46M 0.28% 38
2014
Q3 		$5.52M Buy
+324,474
New +$5.12M 0.43% 21

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

AHL Partners's EW Position: Q4 2017 in Review

AHL Partners increased its Edwards Lifesciences (EW) stake by 35% in Q4 2017, buying an estimated $1.84M and bringing the position to 195,285 shares worth $7.34M. The position accounts for 0.11% of the portfolio, ranked #335.

AHL Partners first reported a position in EW in Q3 2014 and has held it in 14 quarters since. The position peaked at $8.78M in Q2 2015. 772 funds tracked by Wall St. Rank hold EW as of Q4 2017.

  • AHL Partners held 195,285 shares of Edwards Lifesciences worth $7.34M as of Q4 2017.
  • AHL Partners bought 50,232 Edwards Lifesciences shares in Q4 2017, an estimated $1.84M.
  • Edwards Lifesciences made up 0.11% of AHL Partners's portfolio in Q4 2017, its #335 holding.
  • AHL Partners first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Edwards Lifesciences position peaked at $8.78M in Q2 2015.
  • 772 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.